Virinchi
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Virinchi Ltd's board approved a Business Transfer Agreement to acquire the Bristlecone Hospitals primary and secondary healthcare business from its material subsidiary, Virinchi Health Care Private Limited, on a slump sale basis. The deal is valued at ₹100 crores and will see the parent company take over all related assets, liabilities, contracts, and employees with effect from April 1, 2026. The consideration will be settled by adjusting loans and advances already provided by Virinchi Ltd to the subsidiary, meaning no fresh cash outflow is required. The acquisition remains subject to shareholder consent and necessary statutory approvals. The subsidiary's healthcare business, based in Hyderabad, recorded a turnover of ₹133.15 crores in the most recent fiscal year.
Powered by Tijori
Virinchi Ltd's board approved a Business Transfer Agreement to acquire the Bristlecone Hospitals primary and secondary healthcare business from its material subsidiary, Virinchi Health Care Private Limited, on a slump sale basis. The deal is valued at ₹100 crores and will see the parent company take over all related assets, liabilities, contracts, and employees with effect from April 1, 2026. The consideration will be settled by adjusting loans and advances already provided by Virinchi Ltd to the subsidiary, meaning no fresh cash outflow is required. The acquisition remains subject to shareholder consent and necessary statutory approvals. The subsidiary's healthcare business, based in Hyderabad, recorded a turnover of ₹133.15 crores in the most recent fiscal year.
Powered by Tijori
Oct 15 (Reuters) - Virinchi Ltd VIRC.NS:
VIRINCHI LTD - APPROVED RAISING FUNDS VIA PREFERENTIAL ISSUE OF EQUITY WARRANTS
Source text: ID:nBSE9kv4dV
Further company coverage: VIRC.NS
Oct 15 (Reuters) - Virinchi Ltd VIRC.NS:
VIRINCHI LTD - APPROVED RAISING FUNDS VIA PREFERENTIAL ISSUE OF EQUITY WARRANTS
Source text: ID:nBSE9kv4dV
Further company coverage: VIRC.NS
Oct 3 (Reuters) - Virinchi Ltd VIRC.NS:
VIRINCHI LTD - RE-APPOINTS M.V. SRINIVASA RAO AS CFO
Source text for Eikon: ID:nBSE1R4J5C
Further company coverage: VIRC.NS
(([email protected];;))
Oct 3 (Reuters) - Virinchi Ltd VIRC.NS:
VIRINCHI LTD - RE-APPOINTS M.V. SRINIVASA RAO AS CFO
Source text for Eikon: ID:nBSE1R4J5C
Further company coverage: VIRC.NS
(([email protected];;))
Sept 22 (Reuters) - Virinchi Ltd VIRC.NS:
SCHEME OF AMALGAMATION OF SHRI SHRI RESORTS WITH CO STANDS WITHDRAWN WITH IMMEDIATE EFFECT
Source text for Eikon: ID:nBSE8D9jqZ
Further company coverage: VIRC.NS
(([email protected];))
Sept 22 (Reuters) - Virinchi Ltd VIRC.NS:
SCHEME OF AMALGAMATION OF SHRI SHRI RESORTS WITH CO STANDS WITHDRAWN WITH IMMEDIATE EFFECT
Source text for Eikon: ID:nBSE8D9jqZ
Further company coverage: VIRC.NS
(([email protected];))
July 14 (Reuters) - Virinchi Ltd VIRC.NS:
JUNE-QUARTER CONSOL NET PAT 44.1 MILLION RUPEES VERSUS LOSS 18.1 MILLION RUPEES
JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 803 MILLION RUPEES VERSUS 757.9 MILLION RUPEES
Source text for Eikon: ID:nBSE1NjrGf
Further company coverage: VIRC.NS
(([email protected];))
July 14 (Reuters) - Virinchi Ltd VIRC.NS:
JUNE-QUARTER CONSOL NET PAT 44.1 MILLION RUPEES VERSUS LOSS 18.1 MILLION RUPEES
JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 803 MILLION RUPEES VERSUS 757.9 MILLION RUPEES
Source text for Eikon: ID:nBSE1NjrGf
Further company coverage: VIRC.NS
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Virinchi do?
Virinchi Technologies is a global leader in providing software services to the Retail Micro Lending and deferred presentment Industry within the financial services sector.
Who are the competitors of Virinchi?
Virinchi major competitors are Fidel Softech, GVP Infotech, Ducon Infratech., Silicon RentalSolns., Variman Global Enter, All E Technologies, Madala Holdings. Market Cap of Virinchi is ₹175 Crs. While the median market cap of its peers are ₹125 Crs.
Is Virinchi financially stable compared to its competitors?
Virinchi seems to be less financially stable compared to its competitors. Altman Z score of Virinchi is 1.4 and is ranked 8 out of its 8 competitors.
Does Virinchi pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Virinchi latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Virinchi allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Accounts Receivable
How strong is Virinchi balance sheet?
Virinchi balance sheet is weak and might have solvency issues
Is the profitablity of Virinchi improving?
No, profit is decreasing. The profit of Virinchi is -₹27.39 Crs for TTM, ₹0.72 Crs for Mar 2025 and ₹13.7 Crs for Mar 2024.
Is the debt of Virinchi increasing or decreasing?
The net debt of Virinchi is decreasing. Latest net debt of Virinchi is ₹133 Crs as of Mar-26. This is less than Mar-25 when it was ₹145 Crs.
Is Virinchi stock expensive?
Virinchi is not expensive. Latest PE of Virinchi is 12.52, while 3 year average PE is 51.86. Also latest EV/EBITDA of Virinchi is 4.41 while 3yr average is 4.79.
Has the share price of Virinchi grown faster than its competition?
Virinchi has given lower returns compared to its competitors. Virinchi has grown at ~-29.56% over the last 3yrs while peers have grown at a median rate of -17.92%
Is the promoter bullish about Virinchi?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 40.1% and last quarter promoter holding is 37.51%.
Are mutual funds buying/selling Virinchi?
There is Insufficient data to gauge this.